Prevention in liver disease
- PMID: 11217817
- DOI: 10.1097/00000441-200102000-00006
Prevention in liver disease
Abstract
Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.
Similar articles
-
Preventive strategies in chronic liver disease: part II. Cirrhosis.Am Fam Physician. 2001 Nov 15;64(10):1735-40. Am Fam Physician. 2001. PMID: 11759080 Review.
-
Preventive care in chronic liver disease.J Gen Intern Med. 1999 Nov;14(11):699-704. doi: 10.1046/j.1525-1497.1999.11188.x. J Gen Intern Med. 1999. PMID: 10571719 Free PMC article. Review.
-
Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.Ital J Gastroenterol. 1992 Feb;24(2):100-2. Ital J Gastroenterol. 1992. PMID: 1315589
-
[Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):385-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15231157 Chinese.
-
Towards the elimination of hepatitis B and hepatocellular carcinoma.S Afr Med J. 2018 Aug 8;108(8b):13-16. doi: 10.7196/SAMJ.2018.v108i8b.13496. S Afr Med J. 2018. PMID: 30182907 Review.
Cited by
-
Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.Hum Vaccin Immunother. 2013 Nov;9(11):2474-9. doi: 10.4161/hv.25814. Epub 2013 Jul 25. Hum Vaccin Immunother. 2013. PMID: 23887167 Free PMC article. Clinical Trial.
-
Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.World J Gastroenterol. 2003 Nov;9(11):2480-3. doi: 10.3748/wjg.v9.i11.2480. World J Gastroenterol. 2003. PMID: 14606080 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical